GE43220 (Age-Related Macular Degeneration) - Clinical Trial
What is the Purpose of this Study?
Treatment
We are doing this study to gain a better understanding of how iAMD progresses into more advanced stages of the disease.
What is the Condition Being Studied?
Objective
Progression of Intermediate Age-Related Macular Degeneration (iAMD)
Who Can Participate in the Study?
Key Eligibility
Adults ages 50-95 who:
- Are diagnosed with iAMD
- Do not have another macular disease
For more information about who can be in this study, please contact the study team at DEC-RA@duke.edu.
Age Group
Adults
What is Involved?
Description
If you choose to join this observational study, you will come to the research clinic for study visits every 3 months over a period of 3 years.
At various visits, you will have blood tests, answer some questionnaires, and have eye exams and vision tests.
Study Details
Full Title
A Multicenter, Prospective, Observational Study of the Progression of Intermediate Age-Related Macular Degeneration
Principal Investigator
Ophthalmologist
Protocol Number
IRB:
PRO00111176
NCT:
NCT05300724
Phase
Phase
N/A
ClinicalTrials.gov
View on ClinicalTrials.gov
Enrollment Status
Open for Enrollment